Literature DB >> 21556285

A targeted maximum likelihood estimator for two-stage designs.

Sherri Rose1, Mark J van der Laan.   

Abstract

We consider two-stage sampling designs, including so-called nested case control studies, where one takes a random sample from a target population and completes measurements on each subject in the first stage. The second stage involves drawing a subsample from the original sample, collecting additional data on the subsample. This data structure can be viewed as a missing data structure on the full-data structure collected in the second-stage of the study. Methods for analyzing two-stage designs include parametric maximum likelihood estimation and estimating equation methodology. We propose an inverse probability of censoring weighted targeted maximum likelihood estimator (IPCW-TMLE) in two-stage sampling designs and present simulation studies featuring this estimator.

Keywords:  double robust estimation; nested case control studies; targeted maximum likelihood estimators; two-stage designs

Mesh:

Year:  2011        PMID: 21556285      PMCID: PMC3083136          DOI: 10.2202/1557-4679.1217

Source DB:  PubMed          Journal:  Int J Biostat        ISSN: 1557-4679            Impact factor:   0.968


  19 in total

1.  Analysis of case-cohort designs.

Authors:  W E Barlow; L Ichikawa; D Rosner; S Izumi
Journal:  J Clin Epidemiol       Date:  1999-12       Impact factor: 6.437

2.  Efficiency of case-control studies with multiple controls per case: continuous or dichotomous data.

Authors:  H K Ury
Journal:  Biometrics       Date:  1975-09       Impact factor: 2.571

Review 3.  The nested case-control study in cardiology.

Authors:  Vidal Essebag; Jacques Genest; Samy Suissa; Louise Pilote
Journal:  Am Heart J       Date:  2003-10       Impact factor: 4.749

4.  Estimation based on case-control designs with known prevalence probability.

Authors:  Mark J van der Laan
Journal:  Int J Biostat       Date:  2008       Impact factor: 0.968

5.  Simple optimal weighting of cases and controls in case-control studies.

Authors:  Sherri Rose; Mark J van der Laan
Journal:  Int J Biostat       Date:  2008-09-29       Impact factor: 0.968

6.  Why match? Investigating matched case-control study designs with causal effect estimation.

Authors:  Sherri Rose; Mark J van der Laan
Journal:  Int J Biostat       Date:  2009-01-06       Impact factor: 0.968

7.  Analytic methods for two-stage case-control studies and other stratified designs.

Authors:  W D Flanders; S Greenland
Journal:  Stat Med       Date:  1991-05       Impact factor: 2.373

8.  Synthetic retrospective studies and related topics.

Authors:  N Mantel
Journal:  Biometrics       Date:  1973-09       Impact factor: 2.571

9.  A nested case-control study of influenza vaccination was a cost-effective alternative to a full cohort analysis.

Authors:  E Hak; F Wei; D E Grobbee; K L Nichol
Journal:  J Clin Epidemiol       Date:  2004-09       Impact factor: 6.437

10.  Comparison of nested case-control and survival analysis methodologies for analysis of time-dependent exposure.

Authors:  Vidal Essebag; Robert W Platt; Michal Abrahamowicz; Louise Pilote
Journal:  BMC Med Res Methodol       Date:  2005-01-25       Impact factor: 4.615

View more
  12 in total

1.  A double robust approach to causal effects in case-control studies.

Authors:  Sherri Rose; Mark van der Laan
Journal:  Am J Epidemiol       Date:  2014-01-31       Impact factor: 4.897

2.  Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available.

Authors:  Miguel A Hernán; James M Robins
Journal:  Am J Epidemiol       Date:  2016-03-18       Impact factor: 4.897

3.  Designing a Study of Correlates of Risk for Ebola Vaccination.

Authors:  M Elizabeth Halloran; Ira M Longini; Peter B Gilbert
Journal:  Am J Epidemiol       Date:  2020-08-01       Impact factor: 4.897

4.  Considerations for outcome-dependent biased sampling in health databases.

Authors:  Sherri Rose
Journal:  Stat Med       Date:  2019-09-30       Impact factor: 2.373

5.  Post-randomization Biomarker Effect Modification Analysis in an HIV Vaccine Clinical Trial.

Authors:  Peter B Gilbert; Bryan S Blette; Bryan E Shepherd; Michael G Hudgens
Journal:  J Causal Inference       Date:  2020-07-25

6.  Assessing pharmacokinetic marker correlates of outcome, with application to antibody prevention efficacy trials.

Authors:  Peter B Gilbert; Yuanyuan Zhang; Erika Rudnicki; Yunda Huang
Journal:  Stat Med       Date:  2019-07-17       Impact factor: 2.373

7.  Matching and Imputation Methods for Risk Adjustment in the Health Insurance Marketplaces.

Authors:  Sherri Rose; Julie Shi; Thomas G McGuire; Sharon-Lise T Normand
Journal:  Stat Biosci       Date:  2015-08-05

8.  Efficient logistic regression designs under an imperfect population identifier.

Authors:  Paul S Albert; Aiyi Liu; Tonja Nansel
Journal:  Biometrics       Date:  2013-11-21       Impact factor: 2.571

9.  Efficient nonparametric inference on the effects of stochastic interventions under two-phase sampling, with applications to vaccine efficacy trials.

Authors:  Nima S Hejazi; Mark J van der Laan; Holly E Janes; Peter B Gilbert; David C Benkeser
Journal:  Biometrics       Date:  2020-09-28       Impact factor: 2.571

10.  Decreased Susceptibility of Marginal Odds Ratios to Finite-sample Bias.

Authors:  Rachael K Ross; Stephen R Cole; David B Richardson
Journal:  Epidemiology       Date:  2021-09-01       Impact factor: 4.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.